These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31523821)

  • 21. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombophilia in young patients with cryptogenic stroke and patent foramen ovale (PFO).
    Offelli P; Zanchetta M; Pedon L; Marzot F; Cucchini U; Pegoraro C; Iliceto S; Pengo V
    Thromb Haemost; 2007 Oct; 98(4):906-7. PubMed ID: 17938820
    [No Abstract]   [Full Text] [Related]  

  • 23. Cryptogenic stroke in patients with patent foramen ovale.
    Saver JL
    Curr Atheroscler Rep; 2007 Oct; 9(4):319-25. PubMed ID: 18173960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke - Effect of lost-to-follow-up and withdrawal of consent.
    Dellborg M; Eriksson P
    Int J Cardiol; 2016 Mar; 207():308-9. PubMed ID: 26814634
    [No Abstract]   [Full Text] [Related]  

  • 25. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
    Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J
    Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke: Randomized Clinical Trials and Observational Studies.
    Odunukan OW; Price MJ
    Interv Cardiol Clin; 2017 Oct; 6(4):525-538. PubMed ID: 28886843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Closure of Patent Foramen Ovale and Cryptogenic Stroke: Unresolved Issues.
    Diener HC; Gerloff C; Thaler DE; Wöhrle J
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):92. PubMed ID: 30328522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke and patent foramen ovale in young individuals.
    Piechowski-Jozwiak B; Bogousslavsky J
    Eur Neurol; 2013; 69(2):108-17. PubMed ID: 23207510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials.
    Vidale S; Russo F; Campana C; Agostoni E
    Angiology; 2019 Apr; 70(4):325-331. PubMed ID: 30270651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patent foramen ovale and cryptogenic stroke: the hole story.
    Furlan AJ; Jauss M
    Stroke; 2013 Sep; 44(9):2676-8. PubMed ID: 23908069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis.
    Almekhlafi MA; Wilton SB; Rabi DM; Ghali WA; Lorenzetti DL; Hill MD
    Neurology; 2009 Jul; 73(2):89-97. PubMed ID: 19439720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
    Lattanzi S; Brigo F; Cagnetti C; Di Napoli M; Silvestrini M
    Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.
    Vaduganathan M; Qamar A; Gupta A; Bajaj N; Golwala HB; Pandey A; Bhatt DL
    Am J Med; 2018 May; 131(5):575-577. PubMed ID: 29229471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Dalen JE; Alpert JS
    Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patent foramen ovale increases stroke risk in older people.
    Mattle HP; Saver JL
    Nat Rev Neurol; 2018 Oct; 14(10):573-574. PubMed ID: 30054555
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of cerebrovascular events in patients with patent foramen ovale and intracardiac devices.
    Poddar KL; Nagarajan V; Krishnaswamy A; Bajaj NS; Kumari M; Bdair H; Modi D; Agarwal S; Goel SS; Parashar A; Tuzcu EM; Kapadia SR
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1221-6. PubMed ID: 25326741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
    Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.